💥India Is Starting a Semaglutide Price War
Big shift here.
India is not just talking about cheaper Ozempic style drugs anymore. It is already moving.
Semaglutide patent protection has expired in India, and local drugmakers have started launching much cheaper versions. Reports say prices could be up to around 70% lower than the branded products, with more than 40 Indian companies expected to push out dozens of brands.
That does not mean the whole world gets instant cheap supply tomorrow.
The U.S. and Europe still have patent barriers, regulatory rules, and approval hurdles. But it does mean India is now in a strong position to reshape access across its own market first, then pressure prices across parts of Latin America, Asia, Africa, and other lower cost markets over time.
That is the real story.
India may not flood the entire world overnight, but it is already changing the economics of semaglutide and could become one of the biggest forces in the next phase of the global weight loss drug market.
Fact based takeaway: the rollout has started, prices are falling, and the world is now watching what India does next.
#India #Ozempic #Semaglutide #WeightLossDrugs #Pharma #Healthcare #GenericDrugs #Biotech #GlobalHealth #FOMODaily
